Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting-Reference-Cited by-同舟云学术

Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting

Published:2005-02 Issue:2 Volume:65 Page:300-305
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Mochtar C.A.,Kiemeney L.A.L.M.,Laguna M.P.,van Riemsdijk M.M.,Barnett G.S.,Debruyne F.M.J.,de la Rosette J.J.M.C.H.

Publisher

Elsevier BV

Subject

Urology

Reference19 articles.

1. BPH;Emberton;Urology,2003

2. Serum prostate-specific antigen is a powerful predictor of acute urinary retention and the need for surgery in men with clinical benign prostatic hyperplasia;Roehrborn;Urology,1999

3. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate;Roehrborn;Urology,1999

4. Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention;Marberger;Eur Urol,2000

5. for the PLESS Study Group;Kaplan;Urology,2000

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Symptom improvement and predictors associated with improvement after 6 weeks of alpha-blocker therapy: An exploratory, single-arm, open-label cohort study;PLOS ONE;2019-07-25

2. Pre-treatment serum testosterone level can be a useful factor to predict the improvement in bladder outlet obstruction by tadalafil for male patients with lower urinary tract symptoms induced by benign prostatic obstruction;The Aging Male;2019-01-16

3. What Are Factors Contributing to Improvement of Overactive Bladder Symptoms after Alpha-1 Blocker Treatment in Patients with Both Storage and Voiding Symptoms?;Urologia Internationalis;2019

4. Intravesical prostatic protrusion can predict therapeutic response to silodosin in male patients with lower urinary tract symptoms;International Journal of Urology;2017-04-02

5. Assessment of a new point-of-care system for detection of prostate specific antigen;BMC Urology;2016-01-19